Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Change in Cash: 2011-2025

Historic Change in Cash for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $23.2 million.

  • Mimedx Group's Change in Cash rose 17.46% to $23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 million, marking a year-over-year increase of 597.68%. This contributed to the annual value of $22.4 million for FY2024, which is 39.66% up from last year.
  • Latest data reveals that Mimedx Group reported Change in Cash of $23.2 million as of Q3 2025, which was up 86.64% from $12.4 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Change in Cash peaked at $23.2 million during Q3 2025, and registered a low of -$33.5 million during Q1 2024.
  • Moreover, its 3-year median value for Change in Cash was $12.4 million (2025), whereas its average is $6.9 million.
  • Per our database at Business Quant, Mimedx Group's Change in Cash tumbled by 1,316.09% in 2022 and then soared by 1,767.82% in 2024.
  • Quarterly analysis of 5 years shows Mimedx Group's Change in Cash stood at -$3.5 million in 2021, then crashed by 106.21% to -$7.3 million in 2022, then skyrocketed by 111.50% to $836,000 in 2023, then skyrocketed by 1,767.82% to $15.6 million in 2024, then rose by 17.46% to $23.2 million in 2025.
  • Its Change in Cash was $23.2 million in Q3 2025, compared to $12.4 million in Q2 2025 and $2.0 million in Q1 2025.